<![CDATA[Should Medicare’s GLP‑1 Bridge program have an upper age limit?]]>
On July 1, 2026, Medicare has entered new territory in obesity care. For the first time, the Centers for Medicare & Medicaid Services (CMS) is offering broad coverage of glucagon-like peptide 1 (GLP‑1) drugs used primarily for weight loss through the …